Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Some chemotherapy can cause permanent hair loss.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Bimatoprost is safe and effective for improving eyebrow hair.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.